Bhattacharya S. Formulation Design and Development of Anti-EGFR-BSA-CYP-SLNs In Situ Gel for Nasal Administration. AJP [Internet]. 2016 Dec. 29 [cited 2026 Jan. 17];10(04). Available from: https://mail.asiapharmaceutics.info/index.php/ajp/article/view/927